SNP 163364 showed an independent association that also reached genome-wide significance 165 (Table 1) . 166 
167
We further explored the association between the haplotypes (strains) composed of SNPs 168 162215, 162476 and 163364 and NPC risk. Taking the haplotype composed of the 3 low-risk 169 variants (A-T-C) as a reference, we did not observe association for the haplotype carrying the 170 high-risk variant for SNP162215 (C-T-C; odd ratio (OR) = 1.10, P = 0.83), although the 171 number of haplotypes for testing was limited ( Table 2 and Supplementary Table 10 ). Both 172 the haplotypes carrying the high-risk variants of either all the three SNPs or only SNPs 173 162215 and 162476 showed strong risk effect (haplotype C-C-T: OR = 12.10, P = 1.17×10 -25 ; 174 haplotype C-C-C: OR = 3.30, P = 2.20×10 -5 ) ( Table 2 and Supplementary Table 10 ), but 175 the haplotype C-C-T showed significantly stronger effect than the haplotype C-C-C (P = 176
1.85×10
-12 ), clearly indicating the additional risk effect of SNP163364. The haplotype 177 analysis further confirmed that NPC risk is primarily associated with SNPs 162476 and 178 163364, and SNP162215 needs to be further evaluated. We also performed pair-wise 179 interaction analysis showing no evidence for interaction between SNPs 162476 and 163364 180 (P = 0.67). Lastly, we performed a multiple regression analysis that yielded independent risk 181 effects (OR) of 3.15 for SNP 162476_C and 3.68 for SNP 163364_T (Supplementary Table  182 11), which were consistent with the risk effect of the haplotype carrying the two high-risk 183 variants (haplotype C-C-T: OR = 12.10) ( Table 2) . 184
185
The population distribution and phylogenetic analysis of EBV risk haplotypes for NPC 186 In China, the frequency of the two high-risk haplotypes (C-C-T and C-C-C) was very high in 187 the NPC-endemic region (93.27% in NPC cases and 63.04% in controls), but much lower in 188 non-endemic areas (55% in NPC cases, 14.29% in controls) (Supplementary Table 12) . 189
The high-risk haplotypes were also observed in other EBV-associated cancers with a 190 frequency of about 40% in lymphoma patients from the NPC-endemic region and 8.3% in the 191 lymphoma and gastric carcinoma patients from the non-endemic regions. These frequencies 192 are comparable to those observed in healthy controls and much lower than those observed in 193 NPC patients (Supplementary Table 12 ). However, the number of samples from the non-194 endemic region and other EBV-association cancers were much smaller than the NPC samples 195 from the endemic region. Interesting, the two risk haplotypes were absent or extremely rare 196 in non-Asian populations (African and western countries) ( Supplementary Table 12 Table 13 ). Using these 229 strains and C666-1 EBV genome sequence from 204 the current study as well as 97 publicly available genomes, we performed phylogenetic 205 inference analysis and found that the evolutionary relationship among all sequences was 206 highly unbalanced, with a deep split between Type 1 and Type 2 EBV isolates (Fig. 1b) . All 207 Type 2 EBV isolates were geographically restricted to Africa, as previously observed 14, 15, 22 . 208
The Type 1 EBV clade showed a continuous branching starting from Africa, Europe, and 209
Asia, matching the overall distribution along the first PC in the PCA analysis ( Fig. 1b-d) . As 210 shown in previous study 17, 23 , 97% of all 269 EBV isolates were found to be China 1 subtype, 211 and 2% were China 2 (defined by LMP1 classification) (Supplementary Fig. 10 ). Within 212 the Asian group, isolates from NPC-non-endemic areas clustered towards the basal position 213 of the lineage, similar to the pattern observed along the second PC in the PCA map (Fig. 1b-214 d). The most striking pattern in the phylogenetic relationship was a rapid radiation of NPC-215 dominant strains in the endemic population from southern China. EBV genomes from NPC 216 patients appeared to have expanded recently from a common ancestor, and more than half (22 217 of 37) of healthy controls from this region were also infected with NPC-dominant strains (Fig.  218   1b, c) . 219
220
We also mapped the three SNPs of BALF2 (SNP 162215, 162476, and 163364) onto the 221 phylogenetic tree of the EBV genomes. We observed that all the strains carrying the risk 222 variants of SNP162476, and 163364 were within the Asian subclade, whereas the carriers of 223 SNP 162215 had a much broader distribution (Fig. 1b, e) . Within the Asian subclades, the 224 carriers of SNP162476 and 163364 were enriched in the strains from NPC patients (NPC-225 dominant strains). These results provided strong evidence for the Asian origin of SNP162476 226 and 163364 and were consisted with their risk effect on NPC. The results also suggested that 227 SNP 162215 was less likely to be a risk variant for NPC, and its association effect was due to 228 its LD with SNP162476 (LD R-squared = 0.67). 229
230

Functional analysis of EBV BALF2 nonsynonymous variants 231
Since all three risk variants encode amino acid alterations within the BALF2 gene that is 232 responsible for opening the viral DNA for lytic replication. In order to explored the 233 functional role of the three NPC-associated EBV variants, we investigated whether the three 234 viral SNPs influenced viral lytic DNA replication. First, we performed in vitro functional 235 analysis in EBV-positive NPC cell line TW03. After the stimulation of lytic cycle activation, 236
we measured viral DNA abundance within cells that were transfected with the reference 237 haplotype of B95-8 (C-T-C), the low-risk haplotype (A-T-C) and the high-risk haplotype (C-238 C-T) of BALF2 and the empty vector. We found that the viral DNA level was significantly 239 lower in cells carrying the high-risk haplotype compared to cells carrying the other two 240 haplotypes (P < 0.05). No difference was observed between the low-risk and reference 241 haplotypes, and between the high-risk haplotype and the empty vector (Fig. 3a) . These 242 results indicated that both the reference and low-risk haplotypes of BALF2 had similar ability, 243 whereas the high-risk haplotype had weaker ability in supporting EBV lytic DNA replication. 244
Furthermore, we performed an in vivo analysis of the viral DNA abundance in the saliva 245 samples from the 533 NPC cases and 651 healthy controls of the validation sample. We 246 observed a large variation of viral DNA load across the samples, and found that viral DNA 247 abundance in saliva was significantly lower in NPC patients than in healthy controls (P = 248 6.6×10 -15 ) (Fig. 3b) . However, we did not observe the association of the high-risk haplotype 249
(C-C-T) of BALF2 with saliva viral DNA abundance (Supplementary Table 14) . 250
251
Discussion
252
Because of the ubiquity of EBV infection, the determinants of the distinctive geographical 253 distribution of NPC have long puzzled the scientific community. Using large-scale 254 sequencing and functional analyses, we discovered for the first time two EBV coding SNPs 255 162476 and 163364 showing a strong risk effect for NPC. The more than 6-fold increase in 256 NPC risk conferred by these two high-risk EBV variants is far greater than the effects of any 257 other known risk factors for this disease, including host genetic variants ( Table 1) . In 258 particular, with a population frequency of 45% and an OR of 12.10, the EBV haplotype C-T 259 of the two SNPs is the dominant NPC risk factor, contributing 71% (95% confidence interval: 260 67-74%) of the overall risk of NPC in the endemic population of southern China. The second 261 risk haplotype C-C also contributed about 10%, such that the two high-risk EBV haplotypes 262 combined accounted for 83% (95% confidence interval: 79-87%) of NPC risk in this 263 population (Supplementary Table 15) . In non-endemic regions of China, the frequency of 264 these high-risk haplotypes is much lower (about 10%), but they still make a significant 265 contribution (~50%) to NPC risk. The frequency of the two high-risk EBV subtypes was not 266 associated with the risk of developing other EBV-related cancers in our study, suggesting that 267 their oncogenic effects might be specific to NPC. However, this observation would benefit 268 from further work since our study was only powered to explore NPC. 269
270
When we mapped these two causal variants onto the phylogenetic tree of EBV genomes, we 271 observed a distinct subclade of EBV subtypes carrying the two high-risk variants within Asia. 272
The carriers could only be found inside of Asia, which strongly demonstrates the Asian origin 273 of these two risk variants. Most interestingly, the phylogenetic analysis suggests a rapid 274 clonal expansion of these unique high-risk EBV subtypes. This is consistent with the current 275 distribution of these subtypes in China with very high frequency in the NPC-endemic region 276 (93.27% in NPC cases and 63.04% in controls), but much lower in the non-endemic areas (55% 277 in NPC cases, 9.68% in other samples) (Supplementary Table 12 DNA replication complex, we showed that the high-risk haplotype of BALF2 suppressed the 288 lytic DNA replication using the in vitro cell line analysis. Consistently, EBV DNA 289 abundance in saliva was found to be significantly lower in the NPC cases than in controls, 290
suggesting that EBV in buccal epithelium is less lytic in NPC patients. EBV latency promotes 291 the expression of oncogenes and is therefore indispensable for EBV-mediated 292 carcinogenesis 24, 25 , and the expansion of EBV latently-infected nasopharyngeal cells has 293 proven to be an early event in NPC tumorigenesis 26, 27 . Our results demonstrated that the 294 impairment of BALF2 function due to EBV genetic variation potentially promotes viral 295 latency and fosters NPC development by suppressing viral lytic replication. The discovery of 296 these high-risk EBV variants also has major implications for public health efforts to reduce 297 the burden of NPC, particularly in the endemic region of southern China. Testing for these 298 did not find outlier of EBV isolates sequenced in current study (Supplementary Fig. 1 Table 5 ). In addition, when comparing the re-sequenced C666-1 EBV genome against the 375 publicly available sequence 18 , a high concordance rate of 97.93% was found 376 (Supplementary Table 3 and saliva samples of the same patient (intra-host difference) were calculated and compared 385 (Supplementary Fig. 3 ). The median inter-patient difference was 13.5% (1st to 3rd quartile: 386 3.7-16.9%), and the median intra-host difference was only 1.1% (1st to 3rd quartile: 0-3.4%). 387
High concordance rate between saliva and tumor tissue suggests that paired saliva and tumor 388 sample from the same patient are highly similar. Frequencies of high-risk genotypes in discovery, validation and combined analyses are indicated. The association of three EBV SNPs with NPC risk was tested by meta-analysis of the combined discovery and validation phases. Conditional regression analyses were performed in combined data sets and P values of SNP association are listed. Odds ratios conferred by high-risk genotypes and the 95% confidence intervals (CI) were estimated by meta-analysis of combined discovery and validation phases.
